This inventor holds 2 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignee: Invirsa, Inc.. Active years: 2023-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023-2025
Title: Innovations by Anna Kotsakis Ruehlmann
Introduction
Anna Kotsakis Ruehlmann is an accomplished inventor based in Cincinnati, OH. She has made significant contributions to the field of medical research, particularly in the treatment of various diseases. With a total of two patents to her name, her work focuses on innovative methods that address critical health issues.
Latest Patents
Anna's latest patents revolve around the use of 5'-adenosine diphosphate ribose (ADPR). These inventions are directed towards methods for utilizing ADPR and its compositions for treating, managing, or preventing RNA virus-related diseases, herpes virus-related diseases, Sirtuin 6 (Sirt6)-related diseases, Pax6-related diseases, and p53-related diseases. Her research aims to provide new therapeutic options for these conditions.
Career Highlights
Anna Kotsakis Ruehlmann is currently associated with Invirsa, Inc., where she continues to develop her innovative ideas. Her work has garnered attention in the medical community, showcasing her dedication to advancing healthcare solutions.
Collaborations
Anna collaborates with Robert A. Shalwitz, contributing to the development of her groundbreaking inventions. Their partnership exemplifies the importance of teamwork in the pursuit of innovation.
Conclusion
Anna Kotsakis Ruehlmann is a notable inventor whose work in the field of medical research is paving the way for new treatments. Her patents reflect her commitment to addressing significant health challenges through innovation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile